Department of Dermatology, Venereology and Leprosy, J. S. S. Medical College Hospital, J. S. S. University, Mysore, Karnataka, India.
Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):668-78. doi: 10.4103/0378-6323.116735.
Diagnostic accuracy (DA) is an outcome measure to assess the feasibility of teledermatology tools. Despite ample data with variable DA values, no study has examined the aggregate DA value obtained from the available studies and observed its consistency over a period of time. This kind of a longitudinal study about teledermatology will be necessary to check its usefulness and plan for further implementation.
To observe the DA trend over a period of 15 years (1997-2011).
Only those studies (n = 59) using a single tool for general, tertiary, and subspecialty teledermatology practice were included to obtain the DA values. Studies were graded based on the number of subjects and gold standard comparison between teledermatologist and clinical dermatologist (face-to-face examination).
This analysis sought to identify the DA trend was carried out by evaluating 17 store and forward teledermatology (SAFT) based and 8 Video conference (VC) tool-based studies with 2385 and 1305 patients respectively, in comparison with the gold-standard assessment. The average DA was 73.35% ± 14.87% for SAFT and 70.37% ± 7.01% for VC. One sample t-test analysis with 100% accuracy as standard value revealed 28% deficiency for SAFT (t = 7.925; P = 0.000) and 30% deficiency for VC (t = 11.955; P = 0.000). Kruskall-Wallis test confirmed the consistency of DA values in the SAFT (χ2 = 1.852, P = 0.763) tool.
SAFT and VC were adequately validated on a large number of patients by various feasibility studies with the gold standard (face-to-face) comparison between teledermatologists and clinical dermatologists. The DA of SAFT was good, stable over the 15 years and comparable to VC. Health-care providers need to plan for appropriate utility of SAFT either alone or in combination with VC to implement and deliver teledermatology care in India.
诊断准确性(DA)是评估远程皮肤病学工具可行性的一种结果测量方法。尽管有大量具有不同 DA 值的相关数据,但没有研究检查从现有研究中获得的综合 DA 值,并观察其在一段时间内的一致性。对远程皮肤病学进行这种纵向研究对于检查其有用性和计划进一步实施是必要的。
观察 15 年(1997-2011 年)期间的 DA 趋势。
仅纳入使用单一工具进行一般、三级和专科远程皮肤病学实践的研究(n=59)以获得 DA 值。根据受试者数量和远程皮肤病专家与临床皮肤科医生(面对面检查)之间的金标准比较对研究进行分级。
这项分析旨在通过评估 17 项存储转发远程皮肤病学(SAFT)和 8 项视频会议(VC)工具的研究,对 2385 名和 1305 名患者进行了比较,以评估 DA 趋势。与金标准评估相比,SAFT 的平均 DA 为 73.35%±14.87%,VC 的平均 DA 为 70.37%±7.01%。以 100%准确性作为标准值的单样本 t 检验分析显示,SAFT 的缺陷率为 28%(t=7.925;P=0.000),VC 的缺陷率为 30%(t=11.955;P=0.000)。克鲁斯卡尔-沃利斯检验证实了 SAFT(χ2=1.852,P=0.763)工具中 DA 值的一致性。
通过各种可行性研究,使用金标准(面对面)比较远程皮肤科医生和临床皮肤科医生,对大量患者进行了充分的验证。SAFT 和 VC 的 DA 较好,在 15 年内稳定,与 VC 相当。医疗保健提供者需要计划合理利用 SAFT,无论是单独使用还是与 VC 联合使用,以在印度实施和提供远程皮肤病学护理。